Techno Medica (6678) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 period, the Company posted higher revenue and higher profit, with Operating Income increasing at a faster pace than revenue growth; however, the conversion into Net Income was limited. Revenue was ¥72.4B (+12.3% YoY), Operating Income was ¥8.3B (+41.9%), Ordinary Income was ¥8.6B (+46.2%), and Net Income was ¥4.6B (+7.9%). The gross margin declined from 50.3% in the previous year to 47.2%, but the Operating Income margin improved from 9.1% to 11.5% as SG&A expenses decreased 3.0%. Meanwhile, the recognition of an extraordinary loss of ¥1.8B reduced Profit Before Tax by 20.3% from Ordinary Income, and the growth rate of Net Income significantly lagged those at the Operating Income and Ordinary Income levels.

Factors Affecting Financial Results

【Revenue】Revenue was ¥72.4B, representing a 12.3% increase YoY. The increase amounted to ¥7.9B, maintaining double-digit growth.

【Profit and Loss】Operating Income was ¥8.3B (+41.9% YoY), while Ordinary Income was ¥8.6B (+46.2%), representing profit growth substantially exceeding revenue growth. The primary factor was operating leverage resulting from SG&A expenses declining 3.0% YoY to ¥25.9B. Although the gross margin declined by 312bp to 47.2%, this was offset by SG&A efficiencies. However, the recognition of an extraordinary loss of ¥1.8B reduced Profit Before Tax to ¥6.9B, while Net Income remained at ¥4.6B (+7.9%). In conclusion, the Company achieved higher revenue and higher profit at the Operating Income and Ordinary Income levels, while at the bottom-line level it achieved higher revenue and higher profit accompanied by a slowdown in the profit growth rate.

Key Financial Indicators

【Profitability】The Operating Income margin was 11.5%, improving by 239bp from 9.1% in the same period of the previous year, while the gross margin declined by 312bp from 50.3% to 47.2%. The Net Income margin declined slightly from 6.6% to 6.4%.【Cash Flow Quality】DSO was 100 days annualized, DIO was 189 days annualized, and CCC was 229 days annualized. All exceeded the general cautionary benchmarks of 60 days, 90 days, and 120 days, respectively, indicating an extended working capital cycle.【Investment Efficiency】Annualized ROE was approximately 4.2%. The combination of an asset turnover ratio of 0.569x and financial leverage of 1.17x indicates that both asset efficiency and the Net Income margin are constraining factors.【Financial Soundness】The Equity Ratio was 85.4%, the Current Ratio was 729.4%, and the debt-to-equity ratio was 0.17x, maintaining an extremely conservative financial structure centered on cash and deposits of ¥87.5B.

Cash Flow Analysis

Although the Company does not disclose a statement of Operating Cash Flow, cash flow trends can be assessed from movements in the balance sheet. Cash and deposits were ¥87.5B, down ¥3.2B from ¥90.6B in the same period of the previous year, but remained at a high level, accounting for 51.6% of total assets. Accounts payable were ¥8.4B, down 46.6% from ¥15.8B in the previous year, potentially becoming a cash outflow factor due to shortened payment terms or a decline in purchases. Accounts receivable were ¥26.5B, down 19.3% YoY, but DSO remained high at 100 days annualized, indicating room for improvement in collection efficiency. Inventories of finished products were ¥20.9B, with DIO reaching 189 days annualized and CCC at 229 days annualized, reflecting a structure in which working capital efficiency constrains cash generation capacity.

Earnings Quality

Ordinary Income of ¥8.6B consisted essentially of operating-driven profit, calculated as Operating Income of ¥8.3B plus non-operating income of ¥0.4B, including a foreign exchange gain of ¥0.1B, among other items; earnings quality was therefore generally based on the core business. Meanwhile, Profit Before Tax declined 20.3% from Ordinary Income due to the recognition of an extraordinary loss of ¥1.8B, which should be distinguished as a temporary factor. The primary reason for the 239bp improvement in the Operating Income margin was operating leverage resulting from the 3.0% decline in SG&A expenses. Given that the gross margin declined by 312bp, the sustainability of profit growth depends on the continuation of SG&A efficiencies and stabilization of the gross margin. Since Net Income growth (+7.9%) significantly lagged growth at the Operating Income and Ordinary Income levels, underlying earnings power excluding the extraordinary loss is considered stronger than the reported Net Income suggests.

Earnings Forecasts and Guidance

Progress against the full-year Company forecast was 68.3% for Revenue, 56.0% for Operating Income, 58.2% for Ordinary Income, and 41.8% for Net Income. All were below the standard progress benchmark of 75% as of Q3, with the shortfalls particularly significant for Operating Income and Net Income. To achieve the full-year forecast, Operating Income of ¥6.5B and Net Income of ¥6.4B will be required in Q4, representing levels that require a substantial increase over the cumulative Q3 results. The Company forecasts EPS of ¥158.86 and a dividend of ¥68.00, assuming a trend of higher revenue and higher profit; however, based on progress to date, acceleration of earnings in Q4 is a prerequisite for achieving the plan.

Shareholder Returns

The Q2 dividend was ¥0 per share, while the full-year Company forecast is an annual dividend of ¥68.00. The forecast Payout Ratio against forecast EPS of ¥158.86 is 42.8%, below the general sustainability benchmark of 60%. Based on the average number of shares outstanding during the period of 6,934,358 shares, the forecast total dividend amount is approximately ¥4.7B. Given cash and deposits of ¥87.5B and the low debt-to-equity ratio of 0.17x, the Company has sufficient financial capacity to pay dividends. However, as the full-year progress rate for Net Income is only 41.8%, improvement in earnings in Q4 is a prerequisite for achieving the dividend forecast. No disclosure was made regarding share repurchase amounts, and the Total Return Ratio has not been calculated.

Risk Factors

1. Inventory Accumulation Risk: DIO was 189 days annualized, approximately 2.1 times the cautionary benchmark of 90 days. If the sale of ¥20.9B in finished-product inventories is delayed, the gross margin could deteriorate further due to inventory write-downs or discounting.

2. Working Capital Extension Risk: DSO of 100 days and CCC of 229 days both substantially exceed the cautionary benchmarks of 60 days and 120 days, respectively. This reflects a structure in which revenue growth is unlikely to translate directly into cash generation, while the 46.6% decline in Accounts Payable could further reinforce this tendency.

3. Full-Year Plan Achievement Risk: Progress rates for Operating Income and Net Income were 56.0% and 41.8%, respectively, below standard levels, requiring substantial earnings acceleration in Q4. The recurrence of temporary factors such as the ¥1.8B extraordinary loss would make achievement of the plan even more difficult.

Industry Benchmarks (For Reference; Company Analysis)

Profitability and Return

The Operating Income margin exceeds the industry median, while the Net Income margin is at the same level as the industry median.

Growth and Capital Efficiency

The Revenue growth rate significantly exceeds the industry median and is also above the upper bound of the IQR.

※Source: Company analysis

Key Points from the Earnings Results

1. Revenue increased 12.3%, while Operating Income increased 41.9%, clearly demonstrating operating leverage accompanied by SG&A efficiencies. However, the gross margin declined by 312bp, indicating that the sustainability of profit growth depends on stabilization of the gross margin.

2. Due to the recognition of an extraordinary loss of ¥1.8B, Net Income growth was limited to 7.9%, widening the divergence from the Operating Income and Ordinary Income levels. The difference between underlying earnings power excluding temporary factors and reported Net Income is an important consideration when evaluating the earnings results.

3. The working capital indicators of DSO of 100 days, DIO of 189 days, and CCC of 229 days were all at cautionary levels. In contrast to the Company’s financial safety, supported by an extremely high Equity Ratio of 85.4% and liquidity of ¥87.5B in cash and deposits, these indicators represent an observed challenge in terms of capital efficiency.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,936–¥2,047 at ±1% for the cost of equity, and ¥1,987–¥1,992 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value will be below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest Rate Reference Month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---